AIRNA Raises $155M Series B to Fund Alpha-1 Antitrypsin Deficiency
01 Apr 2025 //
BUSINESSWIRE
AIRNA Appoints Matthew Hawryluk as Chief Business Officer
30 Jan 2025 //
BUSINESSWIRE
AIRNA Launches to Develop New Class of RNA Editing Therapeutics
19 Sep 2023 //
BUSINESSWIRE